Company Executives of Park Ha Biological Technology Ord Shs
Name
Name/Position
Position
Shareholding
Change
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
FY2024
FY2023
FY2022
FY2021
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: 6 hours ago
Updated: 6 hours ago
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
18
119.16K
0.35%
-10.79K
2025Q3
18
119.16K
0.35%
-10.79K
2025Q2
15
115.17K
0.39%
+64.73K
2025Q1
6
50.44K
0.19%
-29.47K
2024Q4
4
79.91K
0.30%
+79.91K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Updated: 6 hours ago
Updated: 6 hours ago
Name
Proportion
Invesco Golden Dragon China ETF
0%
Invesco Golden Dragon China ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Park Ha Biological Technology Ord Shs?
The top five shareholders of Park Ha Biological Technology Ord Shs are:
What are the top three shareholder types of Park Ha Biological Technology Ord Shs?
The top three shareholder types of Park Ha Biological Technology Ord Shs are: Other
How many institutions hold shares of Park Ha Biological Technology Ord Shs (BYAH)?
As of 2025Q4, 18 institutions hold shares of Park Ha Biological Technology Ord Shs, with a combined market value of approximately 119.16K, accounting for 0.35% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.00%.
What is the biggest source of revenue for Park Ha Biological Technology Ord Shs?
In FY2024, the -- business generated the highest revenue for Park Ha Biological Technology Ord Shs, amounting to -- and accounting for --% of total revenue.